Micromedic Technologies Ltd.

www.m-medic.com ; www.bio-light.co.il/micromedic

Investment Company

Tech Verticals Preferences

Medical Devices, MedTech

General Data

Established	1982
Current Active Portfolio Companies:	1

DESCRIPTION

Micromedic Technologies Ltd. specializes in the development and commercialization of innovative in vitro cancer diagnostic products and solutions. Its portfolio includes CellDetect, a new-generation cytopathological staining platform for improved early cancer detection and state of the art technology involving gene expression for personalized medicine. Micromedic offers proprietary diagnostic solutions for multiple cancer diagnostic applications, providing practical answers to real unmet needs.

Micromedic is a public company traded on the Tel Aviv Stock Exchange (TASE: MCTC).

REMARKS

Date	Remark
12/08/2020	Micromedic reverse-merged with Nextage Therapeutics Ltd.
01/12/2011	Micromedic is controlled by BioLight Life Sciences Investments (TASE: BOLT), realizing its clusters approach by forming the “Cancer Diagnostic Cluster".

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	Kiryat Atidim, Building 7, Entrance 1, 2rd Floor
City	Tel Aviv
Country	Israel
Zip	6158101

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Former President & CEO, Teva Pharmaceutical Industries
abC Defghij	Vice Chairman	CEO, BioLight
abC Defghij	External Director	Chief Executive Officer, Israel Directors Union

Public Offerings

Deal Date	Type of Offering	Exchange	Amount Raise	Valuation	Remarks
Jan. 22, 2019	Seventh Public Offering	TASE	abCDe	abCDe	NIS 3.4m.
May. 30, 2018	Sixth Public Offering	TASE	abCDe	abCDe	NIS 2.8m.
Dec. 13, 2017	Fifth Public Offering	TASE	abCDe	abCDe
Jul. 13, 2016	Fourth Public Offering	TASE	abCDe	abCDe
Jan. 03, 2013	Third Public Offering	TASE	abCDe	abCDe
Aug. 02, 2010	Second Public Offering	TASE	abCDe	abCDe
Jan. 01, 1993	IPO	TASE	abCDe	abCDe

	FINANCIAL ROUNDS

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

PIPE

Feb. 18, 2013

abCDe

PIPE

Apr. 17, 2012

abCDe

PIPE

Nov. 21, 2011

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij*	Holding Company	abCDe	Biolight purchased 20.6% of the company (and gained control of it) in exchange for 100% Zetiq shares.
abC Defghij	Private Investor	abCDe	Holds 0.5% of the company.

Buyout

May. 24, 2005

abCDe

Avi Ben David, David Solomon, Pareto M&A and Gilon Investments purchased control of Afek Systems. Afek's activity was sold to the former share holders and the new share holders changed its name to Micromedic and redirected it to its current focus.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	N/A	abCDe
abC Defghij	N/A	abCDe

Preferences

Type of Financing	Equity,In-Licensing,Joint R&D
Stage Preferences	R&D,Seed
Phase Preferences	Clinical Trials,Discovery,Phase I,Phase II,Phase III,Pre Clinical

SECTOR SEGMENTATION (By Number Of Companies)

Biomed

100%

	PORTFOLIO COMPANIES

Current Portfolio Companies (1)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Nextage

Biomed

Reverse Merger

12/08/2020

N/A

Historic Portfolio (9)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Bio Gene

Ceased to Operate

Biomed

Seed

05/07/2006

$0.1m

Formed the company and holds 90%

Bio Mark

Ceased to Operate

Biomed

Seed

01/07/2006

$0.47m

Formed the company and holds 90%

Bio Med

Ceased to Operate

Biomed

Seed

22/08/2006

$0.16m

Holds 100% of the company

BioMarCare

Ceased to Operate

Biomed

First Round

27/03/2012

$1m

Holds 53% of the company

Bronj

Ceased to Operate

Biomed

Seed

01/01/2010

$0.35m

The investment is ongoing and was made in parts throughout 2010-2012. Micromedic intends to invest an additional $0.4m during 2013.

Medical Imaging Technologies

Ceased to Operate

First Round

20/09/2005

$0.4m

Holds 15.9% of the company, down from 51%

MET

Written Off

Seed - Extended

09/06/2005

$0.5m

$1.5m

Microrap

Ceased to Operate

Biomed

Seed

01/09/2007

$0.12m

Holds 85% of the company

Zetiq

Ceased to Operate

Biomed

Other

22/09/2011

N/A

Holds 100% of the company, received the shares from BioLight Israel Life Sciences Investments Ltd. in excahge for 21% of its own shares.

Last Updated:	abCDe
IVC Number:	abCDe